Red Light Photobiomodulation (LLLT)

About Light Modulation ® LLLT

Eye-light’s patented photobiomodulation technology solicits cells’ mitochondria, triggering biochemical and biophysical reactions that stimulate them to a better protein synthesis as well as generating endogenous heat through increased ATP generation. Thanks to the near-infrared emission of light, the tear lipid layer is increased and stabilized. On top of the Red Light LLLT, eye-light® also features Blue and Yellow LM® LLLT technology to administer the photobiostimulation therapy for most ocular surface diseases.

LLLT can be safely performed on all patients independent of skin pigmentation and directly treats the eyelids and the periocular area.

Used for Inflammation Reduction and ATP Production Stimulus

• Improves cells metabolism due to increased ATP production within mitochondria
• Reduces inflammation by regulating anti-oxidant defenses and reducing oxidative stress
• Light-induced activation of transcription factors and signaling pathways
• When a 15-minute treatment is applied, the total fluence in the treated area is 100 Joules/cm2
• The photobiomodulation device has an emission power of 100 mW/cm2

More Than Just For Dry Eye Therapy

Known Use Cases in Ophthalmology: DED/MGD, Chalazion, Stye, Sjögren’s Syndrome, Stye, Blepharitis, Ocular Surgery, Ectropion

Fast and Easy Treatments For Staff and Patients Alike

• It’s fast—a treatment lasts 15’
• It’s painless
• It grants immediate relief to the patient
• It’s easy and safe for the operator

It’s plug&play—it doesn’t require the operator to be constantly present during the treatment